Hunter L. Little’s research while affiliated with Stanford University and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (27)


Retinal Injury Due to Industrial Laser Burns
  • Article

March 1981

·

29 Reads

·

63 Citations

Ophthalmology

Edwin E. Boldrey

·

Hunter L. Little

·

Milton Flocks

·

Arthur Vassiliadis

Ocular industrial lasers burns in seven patients were analyzed as to cause, severity, and type of injury. Ocular damage ranged from minimal retinal burns to extensive areas of damage with commotio retinae and vitreous hemorrhage. Visual loss ranged from complete recovery without residual defect to a profound decrease in central acuity. The kinds of lasers causing these injuries were neodymium YAG, argon, krypton, and rhodamine dye. Severity of injury was related to several factors. Some degree of carelessness was involved in all injuries.




Techniques of Argon Laser Photocoagulation of Diabetic Disk New Vessels

December 1976

·

15 Reads

·

27 Citations

American Journal of Ophthalmology

Four argon laser techniques have been evaluated in the eradication of diabetic disk neovascularization: focal (nonfeeder) photocoagulation, feeder-frond photocoagulation alone, panretinal photocoagulation alone, and feeder-frond treatment combined with panretinal photocoagulation. Focal photocoagulation was dangerous and the least effective technique in preventing recurrence of neovascularization. Feeder-frond photocoagulation was effective initially, but was associated with a high incidence of recurrent neovascularization. Panretinal photocoagulation and panretinal photocoagulation combined with feeder-frond treatment produced results superior to those obtained with the two earlier techniques. The best results were obtained with combined feeder-frond and panretinal photocoagulation done concurrently. Early diagnosis, aggressive photocoagulation therapy, and close follow-up were essential in order to obtain good results.


The Effect of Pan-Retinal Photocoagulation on Rubeosis Iridis

July 1976

·

18 Reads

·

126 Citations

American Journal of Ophthalmology

Fifteen eyes of 11 patients with rubeosis iridis and angle neovascularization associated with retinal vascular disorders were treated with pan-retinal photocoagulation. In seven of the 15 eyes, the new vessels on the surface of the iris and in the angle regressed after pan-retinal photocoagulation therapy for disk neovascularization; five of the remaining eight eyes that were treated prospectively demonstrated similar involution of the rubeosis iridis. In three of the five preexisting peripheral anterior synechiae regressed and angle structures previously obscured became visible. Three to 36 months after therapy, three eyes developed a few new abnormal iris and angle vessels.


Complications of Argon Laser Retinal Photocoagulation: A Five-year Study

February 1976

·

25 Reads

·

27 Citations

International Ophthalmology Clinics

The operator must become familiar with the dangers involved with argon laser photocoagulation. The hazards in the use of the argon laser slit-lamp photocoagulator derive from the same properties of the instrument that make it advantageous for the treatment of retinal vascular diseases: the wavelengths are highly absorbed by blood, and the beam can be focused to a small diameter. Of course complications can be avoided entirely by using applications so light the virtually no effect is obtained; but such an approach, although safe, cannot be therapeutic.



Argon Laser Photocoagulation in the Treatment of Presumed Histoplasmic Choroiditis

February 1975

·

4 Reads

·

3 Citations

International Ophthalmology Clinics

Our experience with the evolving techniques we have reported has not resulted in significant increases in visual acuity over pretreatment levels. However, argon laser photocoagulation, properly given, does destroy subretinal neovascularization. The most significant points of technique are (1) heavy treatment of the entire frond; (2) accomplishment of this usually by a 200-mu spot size, 0.2 to 0.5 second, at 300 to 400 mW. power; (3) the eye under retrobulbar anesthesia, and (4) following the case at intervals of three to five days until the neovascular frond is destroyed. If the edge of the neovascular frond is within 200 mu of the fovea, treatment presents a very definite hazard to foveal vision and should be attempted only in the most experienced hands and on only the best-informed patients.


Recurrent Choroidal Neovascularization Following Argon Laser Photocoagulation of Histoplasmic Maculopathy

February 1975

·

5 Reads

·

37 Citations

International Ophthalmology Clinics

Early detection of recurrent or inadequately obliterated choroidal neovascularization can be achieved by repeating fluorescein angiography at one week and at one month after treatment. Immediate and intensely heavy photocoagulation of the recurrent vessels is recommended. Advisable settings are 200 μ. 400 mW. at 0.2 or 0.5 second, and 500 μ with 700 mW. at 0.2 or 0.5 second. Repeated slit lamp evaluation is advised until all fluid is resolved and all leakage on the angiogram is sealed. The patient is then followed up every six months, or earlier if he or she notes recurrent distortion on the Amsler grid, which the patient is advised to check three times weekly.



Citations (13)


... Indocyanine green (ICG) angiography reveals hyperfluorescent areas that correspond to leaking points, and the choroid appears partly hypofluorescent owing to RPE atrophy and partly hyperfluorescent owing to the choriocapillary hyperpermeability. [2][3][4] Optical coherence tomographic (OCT) examinations reveal subretinal fluid and an irregular profile of the internal margin of the neurosensory retinal detachment secondary to a thickening and elongation of photoreceptor outer segments. A double-layer sign may appear with an undulating RPE profile, a hyporeflective middle layer, and an intact or slightly thickened Bruch membrane. ...

Reference:

Chronic Central Serous Chorioretinopathy Imaged by Optical Coherence Tomographic Angiography
Diffuse retinal pigment epitheliopathy
  • Citing Article
  • January 1977

... These conditions cause leakage in the retinal vessels and neovascularization, leading to proliferative retinopathy. Panretinal laser photocoagulation (PRP) is the gold standard treatment for severe retinal ischemic diseases, including PDR [7][8][9][10] and rubeosis iridis, which arise from ischemic CRVO [11,12]. There is strong evidence that PRP prevents the development of NVG in PDR [7]. ...

The Effect of Pan-Retinal Photocoagulation on Rubeosis Iridis
  • Citing Article
  • July 1976

American Journal of Ophthalmology

... In recent years, various treatment approaches have been reported for chronic CSC. Conventional laser treatments can induce thermal injuries in the retina, they have also side effects such as visual field defects, focal scar enlargement, CNV, and the development of new leak sites [17]. PDT, another alternative therapy, has achieved successful anatomical outcomes in the treatment of chronic CSC, but has various side effects such as choroidal ischemia, rupture or RPE atrophy, and CNV [6,[18][19][20][21]. ...

Complications of Argon Laser Retinal Photocoagulation: A Five-year Study
  • Citing Article
  • February 1976

International Ophthalmology Clinics

... B Qiang Wu qiang.wu@shsmu.edu.cn 1 Department of Ophthalmology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China the clinical practice for diagnosing and monitoring NV [11]. However, ophthalmologists or specially qualified technicians and graders may need to manually analyze a few crosssectional OCT B-scan pictures from the volumetric scan slice by slice to identify NVD from OCTA images and determine blood flow information. ...

Techniques of Argon Laser Photocoagulation of Diabetic Disk New Vessels
  • Citing Article
  • December 1976

American Journal of Ophthalmology

... The argon green laser trial of extrafoveal CNV (200–2500 lm from the center of the foveal avascular zone) showed 25% and 60% severe visual loss in treated and untreated patients, respectively [14]. However, 59% of treated patients developed recurrent neovascularization, often soon after treatment (24% at 6 months, 43% by 1 year) [15]. The krypton red laser study treated juxtafoveal CNV lesions with a posterior border 1 to 199 lm from the center of the foveal avascular zone. ...

Recurrent Choroidal Neovascularization Following Argon Laser Photocoagulation of Histoplasmic Maculopathy
  • Citing Article
  • February 1975

International Ophthalmology Clinics

... In the current study, all patients who developed early postoperative VH were phakic, showed active fibrovascular membranes and none experienced ocular hypotony. Preoperative panretinal photocoagulation was not performed due to the risk of contraction of preretinal membranes [22][23][24], instead it was performed at end of surgery. To reduce the risk of intraoperative bleeding, IVB was injected 3-5 days prior to surgery in this series, but no more than 5 days to avoid causing fibrovascular contraction and subsequent worsening of the retinal detachment [25][26][27]. ...

Complications of argon laser photocoagulation
  • Citing Article
  • January 1974

Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology

... Способ доставки -ключевой аспект лазерной фототерапии. В то время как рубиновый лазер был адаптирован к монокулярному прямому офтальмоскопу, последующие поколения лазеров стали адаптировать к непрямому офтальмоскопу [4], щелевой лампе [5] и операционному микроскопу [6]. Сочетание лазеров со щелевой лампой улучшило доставку лазерного излучения, особенно для его применения в области заднего полюса глаза, что позволило проводить лечение широкого спектра заболеваний сетчатки и хориоидеи в амбулаторных условиях. ...

Argon Laser Slit-Lamp Retinal Photocoagulation
  • Citing Article
  • January 1970

Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology

... It is apocryphal that early in the experience of the rapidly growing post-insulin DR epidemic it was noted that eyes with large chorioretinal scars, such as from trauma or congenital toxoplasmosis, appeared to be protected from DR compared to otherwise normal fellow eyes (L'Esperance 1966). This observation gave rise to the idea of creating chorioretinal scarring as a therapeutic measure to treat or prevent DR (L' Esperance 1966, Zweng et al 1971, Townsend et al 1978. It was recognized that laser (or xenon arc) could produce photocoagulation (PC) scars that could mimic the traumatic and infectious lesions that appeared to confer protection. ...

Argon Laser Photocoagulation of Diabetic Retinopathy
  • Citing Article
  • November 1971

Archives of Ophthalmology

... Retinal photocoagulation (RPC) for complications of diabetic retinopathy (DR) and retinal vein occlusion (RVO) became major indications for retinal laser, principally as focal and grid RPC, while treatment of choroidal neovascular membranes (CNV), particularly associated with age-related macular degeneration (AMD), was the unique indication for suprathreshold ablative RPC in the macula [15,16] Despite steady progress in most other areas of ophthalmology, prototypical LIRD, i.e., photocoagulation, was believed to be the absolute prerequisite for therapeutic efficacy and remained so for over 50 years. This belief was universally accepted and questioned by no one of record during that time [17]. ...

Treatment of retinal vascular disease with argon laser slit lamp photocoagulation.
  • Citing Article
  • February 1970

Transactions of the Pacific Coast Oto-Ophthalmological Society annual meeting